BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Immunology Podcast
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211012
DTEND;VALUE=DATE:20211013
DTSTAMP:20230120T172504Z
CREATED:20210928T171431Z
LAST-MODIFIED:20230120T172504Z
UID:3741-1633996800-1634083199@www.immunologypodcast.com
SUMMARY:Dr. Anil Bhushan
DESCRIPTION:Dr. Anil Bhushan is a Professor at the University of California\, San Francisco. His lab focuses on understanding how the immune system senses and tunes its response to senescent cells in disease and aging. His lab was one of the first to show the role of clearing senescent cells in models of Type 1 diabetes. They are interested in identifying and targeting the endogenous immune surveillance mechanism that can promote elimination of senescent cells and reverse disease progression. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-anil-bhushan
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/09/Anil-Bhushan-Square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20210929
DTSTAMP:20230120T172450Z
CREATED:20210708T214636Z
LAST-MODIFIED:20230120T172450Z
UID:3687-1632787200-1632873599@www.immunologypodcast.com
SUMMARY:Dr. Michael Burton
DESCRIPTION:Dr. Michael Burton is an Assistant Professor at the University of Texas in Dallas. His lab studies the complex interactions between the immune and nervous systems that lead to pain\, depression\, and sickness\, with special interests in the influence of age and the endogenous cannabinoid system. He believes in order to traverse the gap between basic research and clinical application to the patient\, we must realize and appreciate pre-clinical research. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-burton
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Michael-Burton-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210914
DTEND;VALUE=DATE:20210915
DTSTAMP:20230120T172438Z
CREATED:20210708T211123Z
LAST-MODIFIED:20230120T172438Z
UID:3684-1631577600-1631663999@www.immunologypodcast.com
SUMMARY:Dr. Frances Lund
DESCRIPTION:Dr. Frances Lund is the Charles H. McCauley Professor and Chair of the Department of Microbiology at the University of Alabama at Birmingham. Dr. Lund is most well known for the work from her laboratory showing that B lymphocytes have a larger role in the immune response than previously appreciated. While scientists have long recognized that B cells make antibodies that label bacteria and viruses for destruction by the immune system\, Dr. Lund’s group showed that B cells also produce chemical signaling molecules called cytokines and demonstrated that the cytokines made specifically by B cells can alter the magnitude\, duration and quality of the immune response that is generated in response to pathogens\, allergens and autoantigens. Today her laboratory focuses on developing methods to identify and eliminate B cells that contribute to autoimmune or allergic disease pathogenesis while maintaining the protective pathogen-specific B cell subsets. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-frances-lund
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Frances-Lund-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210831
DTEND;VALUE=DATE:20210901
DTSTAMP:20230120T172425Z
CREATED:20210824T194933Z
LAST-MODIFIED:20230120T172425Z
UID:3724-1630368000-1630454399@www.immunologypodcast.com
SUMMARY:Dr. Jeffrey Bluestone
DESCRIPTION:Dr. Jeffrey Bluestone is the CEO and President of Sonoma Biotherapeutics\, which is leveraging the properties of regulatory T cells to create living cell therapies that restore the immune system back to its balanced\, fully functioning state. He was previously a Professor at the Diabetes Center at the University of California San Francisco\, and his research over the past 25 years has focused on understanding the basic processes that control T cell activation and immune tolerance in autoimmunity and organ transplantation. \n  \nImage by Steve Babuljak\, courtesy of Dr. Jeff Bluestone \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jeffrey-bluestone
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/08/jeffrey-bluestone-portrait.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210817
DTEND;VALUE=DATE:20210818
DTSTAMP:20230120T172408Z
CREATED:20210708T205331Z
LAST-MODIFIED:20230120T172408Z
UID:3681-1629158400-1629244799@www.immunologypodcast.com
SUMMARY:Dr. Christopher Klebanoff
DESCRIPTION:Dr. Christopher Klebanoff is a medical oncologist and translational researcher whose focus is on providing the best care possible to people with breast cancer. He is a member of the Center for Cell Engineering and the Parker Institute for Cancer Immunotherapy at the Memorial Sloan Kettering Cancer Center\, and is particularly interested in cell-based cancer immunotherapies\, T cell receptors\, and the therapeutic targeting of shared cancer neoantigens. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-christopher-klebanoff
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/07/Christopher-Klebanoff.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210803
DTEND;VALUE=DATE:20210804
DTSTAMP:20230120T172355Z
CREATED:20210611T220237Z
LAST-MODIFIED:20230120T172355Z
UID:3666-1627948800-1628035199@www.immunologypodcast.com
SUMMARY:Dr. James Crowe
DESCRIPTION:Dr. James Crowe is the Director of the Vanderbilt Vaccine Center. Their group uses a very broad array of techniques including molecular and cellular biology\, state-of-the-art imaging and flow cytometry\, bioinformatics\, and bioengineering approaches to attack the scientific problems that are of interest to them: major human pathogens. These pathogens include respiratory syncytial virus\, human metapneumovirus\, rotavirus\, HIV\, influenza\, and vaccinia virus. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-james-crowe
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/06/James-Crowe.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210720
DTEND;VALUE=DATE:20210721
DTSTAMP:20230120T172341Z
CREATED:20210611T211007Z
LAST-MODIFIED:20230120T172341Z
UID:3662-1626739200-1626825599@www.immunologypodcast.com
SUMMARY:Dr. Marc Jenkins
DESCRIPTION:Dr. Marc Jenkins is a Regents and Distinguished McKnight University Professor  in the Department of Microbiology and Immunology at the University of Minnesota. The Jenkins lab is focused on the basic biology of CD4+ T lymphocytes. They investigate CD4+ T and B cell activation in vivo by directly tracking antigen-specific cells. The goal of this research is a basic understanding of lymphocyte activation that can be used to improve vaccines and prevent autoimmunity. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-marc-jenkins
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/06/Marc-Jenkins-Square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210706
DTEND;VALUE=DATE:20210707
DTSTAMP:20230120T173323Z
CREATED:20210611T195501Z
LAST-MODIFIED:20230120T173323Z
UID:3655-1625529600-1625615999@www.immunologypodcast.com
SUMMARY:Dr. Robyn Hall
DESCRIPTION:Dr. Robyn Hall is a Research Scientist and Team Leader at the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Her current research is focused on understanding the epidemiology of lagoviruses in the Australian landscape and how they interact with each other\, understanding the fundamental biology of these viruses\, and investigating the ways in which these viruses evolve. She is particularly interested in the role of recombination in the evolution of the caliciviruses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-robyn-hall
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/06/robyn-hall-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210623
DTSTAMP:20230120T173309Z
CREATED:20210519T173503Z
LAST-MODIFIED:20230120T173309Z
UID:3633-1624320000-1624406399@www.immunologypodcast.com
SUMMARY:Drs. Isaac Chiu and Tiphaine Voisin
DESCRIPTION:Dr. Isaac Chiu is an Assistant Professor in the Department of Immunology at Harvard Medical School. His research focuses on interactions between the nervous system\, immune system\, and microbes in pain\, host defense and inflammation. Dr. Tiphaine Voisin is a former postdoctoral fellow in the Chiu lab whose project focused on the role of cysteinyl leukotrienes in chronic itch. \nRead their recent PNAS paper on chronic itch. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-isaac-chiu-and-tiphaine-voisin
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/05/Isaac-Chiu-and-Tiphaine-Voisin.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210609
DTSTAMP:20230120T173255Z
CREATED:20210224T215017Z
LAST-MODIFIED:20230120T173255Z
UID:3530-1623110400-1623196799@www.immunologypodcast.com
SUMMARY:Dr. Daniela Thommen
DESCRIPTION:Dr. Daniela Thommen is a Group Leader at the Netherlands Cancer Institute. Her lab is interested in understanding how human cancers immunologically respond to treatment\, and how such responses relate to the immunological makeup of a tumor. \nListen to the episode here. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-daniela-thommen
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/02/Daniela-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210525
DTEND;VALUE=DATE:20210526
DTSTAMP:20230120T173240Z
CREATED:20210224T223509Z
LAST-MODIFIED:20230120T173240Z
UID:3536-1621900800-1621987199@www.immunologypodcast.com
SUMMARY:Dr. Judy Lieberman and Dr. Caroline Junqueira
DESCRIPTION:Dr. Judy Lieberman is a Professor of Pediatrics at Harvard Medical School and holds an endowed chair in Cellular and Molecular Medicine at Boston Children’s Hospital. Dr. Caroline Junqueira is an Investigator at the Oswaldo Cruz Foundation and a visiting scientist at Harvard Medical School. Both researchers are interested in cytotoxic T lymphocytes — key cells in the immune defense against viral infection and cancer. \nRead their recent Nature Immunology paper showing that activated γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis here. \nListen to the episode here. \n  \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-judy-lieberman-and-dr-caroline-junqueira
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/05/Judy-and-Caroline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210511
DTEND;VALUE=DATE:20210512
DTSTAMP:20230120T173227Z
CREATED:20210224T221138Z
LAST-MODIFIED:20230120T173227Z
UID:3533-1620691200-1620777599@www.immunologypodcast.com
SUMMARY:Dr. Carl June and Dr. Philipp Rommel
DESCRIPTION:Dr. Carl June is the Richard W. Vague Professor in Immunology at the University of Pennsylvania\, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine\, and Director of the Parker Institute for Cancer Immunotherapy. Dr. Philipp Rommel is a Postdoctoral Researcher in the June lab. Together\, they are interested in lymphocyte biology\, with a major translational focus on ex vivo T-cell engineering for cancer and HIV cell-based therapies. \nListen to the episode here. \n  \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-carl-june-and-dr-philipp-rommel
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2021/02/Carl-and-Philipp-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210428
DTSTAMP:20230120T173214Z
CREATED:20210212T001902Z
LAST-MODIFIED:20230120T173214Z
UID:3511-1619481600-1619567999@www.immunologypodcast.com
SUMMARY:Dr. Bernardo Franklin
DESCRIPTION:Dr. Bernardo Franklin is a Professor at the University of Bonn. His lab studies the role of innate immunity in sterile inflammation and in infectious diseases. More recently\, their research has focused on blood platelets and their effects on innate immunity\, systemic inflammation and cancer. \nRead his recent paper in Cell Reports exploring how platelets fuel the inflammasome activation of innate immune cells here. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-bernardo-franklin
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/02/Bernardo-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210413
DTEND;VALUE=DATE:20210414
DTSTAMP:20230120T173159Z
CREATED:20210224T224833Z
LAST-MODIFIED:20230120T173159Z
UID:3539-1618272000-1618358399@www.immunologypodcast.com
SUMMARY:Drs. Mindy\, Amy\, and Kristen Engevik
DESCRIPTION:Drs. Mindy\, Amy\, and Kristen Engevik are sisters and immunologists. Mindy is an Assistant Professor at the Medical University of South Carolina\, Amy is a Postdoctoral Fellow at Vanderbilt University who will soon be starting up her own lab alongside Mindy at the Medical University of South Carolina\, and Kristen is a Postdoctoral Fellow at Baylor College of Medicine. \nFollow the sisters and their research on Twitter using the hashtag #sisterlab. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-mindy-amy-and-kristen-engevik
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/04/image-engevik-sisters.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210330
DTEND;VALUE=DATE:20210331
DTSTAMP:20230120T173145Z
CREATED:20210212T002941Z
LAST-MODIFIED:20230120T173145Z
UID:3514-1617062400-1617148799@www.immunologypodcast.com
SUMMARY:Dr. Filipe Pereira
DESCRIPTION:Dr. Filipe Pereira is an Associate Professor at the Lund Stem Cell Center at Lund Unversity. His research focuses on how hematopoietic cell fate is specified\, maintained\, and eventually modified or reversed. His lab uses an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate their findings into novel gene and cell therapies. \nRead his recent paper on the development of a protocol for direct reprogramming of mouse embryonic fibroblasts to conventional tyle 1 dendritic cells disorders here. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-filipe-pereira
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2021/02/FilipePereira-1-scaled.jpg
END:VEVENT
END:VCALENDAR